{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:09:00Z","timestamp":1793174940941,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.clinre.2021.101843","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T02:12:24Z","timestamp":1639620744000},"page":"101843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study"],"prefix":"10.1016","volume":"46","author":[{"given":"Xuan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongji","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7837-0392","authenticated-orcid":false,"given":"Honghui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2021.101843_bib0001","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101843_bib0002","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/hep.29724","article-title":"Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101843_bib0003","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/jgh.14989","article-title":"Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population","volume":"35","author":"Kogiso","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2021.101843_bib0004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2021.101843_bib0005","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101843_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101710","article-title":"Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target","volume":"45","author":"Colak","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2021.101843_bib0007","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.clinre.2021.101843_bib0008","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2017.11.040","article-title":"Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice","volume":"68","author":"Xu","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2021.101843_bib0009","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101843_bib0010","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.clinre.2021.101843_bib0011","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2021.101843_bib0012","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.intimp.2019.02.016","article-title":"The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice","volume":"70","author":"Qu","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.clinre.2021.101843_bib0013","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jnutbio.2016.04.004","article-title":"Fish-oil-derived n-3 polyunsaturated fatty acids reduce NLRP3 inflammasome activity and obesity-related inflammatory cross-talk between adipocytes and CD11b(+) macrophages","volume":"34","author":"De Boer","year":"2016","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.clinre.2021.101843_bib0014","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/s41423-020-00545-z","article-title":"Synthetic vitamin K analogs inhibit inflammation by targeting the NLRP3 inflammasome","volume":"18","author":"Zheng","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.clinre.2021.101843_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153238","article-title":"Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: a review","volume":"75","author":"Olcum","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.clinre.2021.101843_bib0016","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2019.05.005","article-title":"Antiobesity effects of anthocyanins on mitochondrial biogenesis, inflammation, and oxidative stress: a systematic review","volume":"66","author":"Gomes","year":"2019","journal-title":"Nutrition"},{"key":"10.1016\/j.clinre.2021.101843_bib0017","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.freeradbiomed.2020.08.006","article-title":"Cyanidin-3-O-beta-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1\/NF-kappaB signaling pathway","volume":"160","author":"Zhou","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.clinre.2021.101843_bib0018","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jnutbio.2017.10.012","article-title":"Red raspberries suppress NLRP3 inflammasome and attenuate metabolic abnormalities in diet-induced obese mice","volume":"53","author":"Zhu","year":"2018","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.clinre.2021.101843_bib0019","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1097\/MD.0000000000000758","article-title":"A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinre.2021.101843_bib0020","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/01.CIR.0000142055.53122.FA","article-title":"Circulating mononuclear cells in the obese are in a proinflammatory state","volume":"110","author":"Ghanim","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinre.2021.101843_bib0021","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1017\/S0007114516002993","article-title":"Differences in metabolic biomarkers in the blood and gene expression profiles of peripheral blood mononuclear cells among normal weight, mildly obese and moderately obese subjects","volume":"116","author":"Jung","year":"2016","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clinre.2021.101843_bib0022","doi-asserted-by":"crossref","first-page":"16494","DOI":"10.1038\/srep16494","article-title":"ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinre.2021.101843_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6489012","article-title":"Role of NLRP3 inflammasome in the progression of NAFLD to NASH","volume":"2016","author":"Wan","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2021.101843_bib0024","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/db12-0420","article-title":"Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes","volume":"62","author":"Lee","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.clinre.2021.101843_bib0025","first-page":"1826","article-title":"NLRP3 inflammasome expression in peripheral blood monocytes of coronary heart disease patients and its modulation by rosuvastatin","volume":"20","author":"Zhu","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.clinre.2021.101843_bib0026","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2020.08.011","article-title":"Inhibition of interleukin-1beta and reduction in atherothrombotic cardiovascular events in the CANTOS Trial","volume":"76","author":"Everett","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinre.2021.101843_bib0027","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00394-019-02024-2","article-title":"Obesity-related inflammatory modulation by jucara berry (Euterpe edulis Mart.) supplementation in Brazilian adults: a double-blind randomized controlled trial","volume":"59","author":"Santamarina","year":"2020","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clinre.2021.101843_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2019.103596","article-title":"Anthocyanin supplementation inhibits secretion of pro-inflammatory cytokines in overweight and obese individuals","volume":"64","author":"Vugic","year":"2020","journal-title":"J Funct Foods"},{"key":"10.1016\/j.clinre.2021.101843_bib0029","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.2174\/0929867325666181112093336","article-title":"Anthocyanins as modulators of cell redox-dependent pathways in non-communicable diseases","volume":"27","author":"Speciale","year":"2020","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.clinre.2021.101843_bib0030","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/ptr.5642","article-title":"Chemistry, pharmacology and health benefits of anthocyanins","volume":"30","author":"Smeriglio","year":"2016","journal-title":"Phytother Res"},{"key":"10.1016\/j.clinre.2021.101843_bib0031","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4162\/nrp.2017.11.5.357","article-title":"Black soybean anthocyanins attenuate inflammatory responses by suppressing reactive oxygen species production and mitogen activated protein kinases signaling in lipopolysaccharide-stimulated macrophages","volume":"11","author":"Kim","year":"2017","journal-title":"Nutr Res Pract"},{"key":"10.1016\/j.clinre.2021.101843_bib0032","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/ptr.6379","article-title":"Anthocyanins ameliorate palmitate-induced inflammation and insulin resistance in 3T3-L1 adipocytes","volume":"33","author":"Muscar\u00e0","year":"2019","journal-title":"Phytother Res"},{"key":"10.1016\/j.clinre.2021.101843_bib0033","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/ijms19030816","article-title":"Anthocyanin-rich extract from red chinese cabbage alleviates vascular inflammation in endothelial cells and Apo E(-\/-) Mice","volume":"19","author":"Joo","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinre.2021.101843_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.110745","article-title":"A dose-response evaluation of purified anthocyanins on inflammatory and oxidative biomarkers and metabolic risk factors in healthy young adults: a randomized controlled trial","volume":"74","author":"Guo","year":"2020","journal-title":"Nutrition"},{"key":"10.1016\/j.clinre.2021.101843_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101474","article-title":"Anthocyanin supplementation improves anti-oxidative and anti-inflammatory capacity in a dose-response manner in subjects with dyslipidemia","volume":"32","author":"Zhang","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.clinre.2021.101843_bib0036","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3390\/nu9101104","article-title":"Role of purified anthocyanins in improving cardiometabolic risk factors in chinese men and women with prediabetes or early untreated diabetes-A randomized controlled trial","volume":"9","author":"Yang","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.clinre.2021.101843_bib0037","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41430-020-0609-4","article-title":"Anthocyanin supplementation at different doses improves cholesterol efflux capacity in subjects with dyslipidemia-a randomized controlled trial","volume":"75","author":"Xu","year":"2021","journal-title":"Eur J Clin Nutr"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740121002217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740121002217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:33:20Z","timestamp":1761896000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740121002217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2210740121002217"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101843","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101843"}}